Monitor for any subsequent prospectus supplement or takedown notice, which would signal an actual offering. The shelf becoming effective is a procedural step; the stock is unlikely to react until a specific offering is announced.
PALI drugs
PALI drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 22 $1.95entry
- T+1 · 6mo ago +2.05%α +1.47% · $1.99
- T+5 · 6mo ago +6.67%α +5.01% · $2.08
- T+20 · 5mo ago −3.08%α −1.66% · $1.89
- T+60 · 3mo ago +4.62%α +1.43% · $2.04
Price Chart
How similar events traded
Executive Summary
Palisade Bio's $300M universal shelf registration (File No. 333-295815) became effective on May 21, 2026, enabling the company to offer and sell securities at any time. The company had $132.6M in cash as of March 31, 2026, and management has stated existing cash funds operations through key Phase 2 readouts in 2H 2027 and early 2028, suggesting this is an opportunistic shelf filing rather than an imminent dilutive event.
Key Facts
- Shelf registration (File No. 333-295815) declared effective on May 21, 2026.
- Company reported $132.6M in cash as of March 31, 2026.
- Management states existing cash funds operations through Phase 2 readouts in 2H 2027 and early 2028.
- Shelf provides maximum flexibility for future capital raises but no immediate offering announced.
Financial Impact
Up to $300M in potential future offerings, but no immediate dilution as no takedown has occurred.
Risk Factors
- Potential future dilution if the company conducts an offering under the shelf.
- Market may perceive shelf effectiveness as overhang, especially for a pre-revenue biotech.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001731 |
| Document: 9999999995-26-001731-index.html | 9999999995-26-001731 |
| Document: 9999999995-26-001731.txt | 9999999995-26-001731 |
Track record
14 reports on PALI
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.08 Now $1.03 −4.19% settles Dec 15
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $1.17 Now $1.03 −11.97% settles Dec 10
- Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $1.13 Now $1.03 −8.85% settles Dec 9
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $1.16 Now $1.03 −11.21% settles Nov 30
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $1.69 to $1.43 Now $1.03 −39.05% ▼ −15.38% −14.82% vs SPY
- Sep 22, 20267w ago Press Release Bullish 6/10 Entry $1.69 to $1.43 Now $1.03 −39.05% ▼ −15.38% −14.82% vs SPY
- Aug 10, 202614w ago 8-K Neutral 5/10 Entry $2.14 to $2.05 Now $1.03 −51.87% ▼ −4.21% −3.15% vs SPY
- Jul 10, 202618w ago Insider Cluster Neutral 2/10 Entry $1.89 to $2.10 Now $1.03 −45.50% ▲ +11.11% +7.93% vs SPY
- Jul 8, 202618w ago Insider Cluster Neutral 3/10 Entry $1.97 to $2.09 Now $1.03 −47.72% ▲ +6.09% +3.85% vs SPY
- Jun 11, 202622w ago 8-K Neutral 4/10 Entry $1.71 to $1.96 Now $1.03 −39.77% ▲ +14.62% +12.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers